Story excerpt provided by Crain’s Cleveland Business.
Written by Dan Shingler.
When Boston-based medical device company Myomo rang the bell of the New York Stock Exchange on June 16, it was doing more than heralding the company’s first-of-its-kind, $5 million initial public offering of stock.
It was also a sort of ringing endorsement of Northeast Ohio’s efforts to advance its own medical-manufacturing economy.
Myomo CEO Paul Gudonis said the Northeast Ohio region has been important to his company’s success to date, because it’s where Myomo has found partners for its research, facilities for its testing — and even a highly specialized manufacturer to make its high-tech medical devices.
Click here to read the complete article.
Originally published June 25, 2017.